INVESTMENTS

Fresenius plans to invest in further growth in 2009, increasing capital expenditure in property, plant, and equipment by about € 700 to 750 million, a figure slightly below the very high € 764 million invested in 2008. About 60 % of the capital expenditure will be invested at Fresenius Medical Care, while Fresenius Kabi and Fresenius Helios will each account for over 15%. Investments at Fresenius Medical Care will be concentrated on the construction and expansion of dialysis clinics, and on the maintenance and expansion of production plants. Fresenius Kabi will invest in expanding and maintaining production facilities and in introducing new manufacturing technologies, enabling further improvements in production efficiency. At Fresenius Helios, we will be investing primarily in modernizing hospitals and in hospital equipment. The regional focus of the investments will be on Europe and North America, which will account for about 50% and 35%, respectively. The remainder will be invested in Asia, Latin America, and Africa. About 30% of the funds will be invested in Germany.